EFG Asset Management Americas Corp. Buys Shares of 20,882 Astera Labs, Inc. $ALAB

EFG Asset Management Americas Corp. purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, HoldingsChannel reports. The fund purchased 20,882 shares of the company’s stock, valued at approximately $1,888,000.

A number of other large investors have also recently added to or reduced their stakes in ALAB. Oliver Lagore Vanvalin Investment Group bought a new stake in shares of Astera Labs in the 2nd quarter worth about $29,000. Bernard Wealth Management Corp. bought a new stake in Astera Labs in the second quarter valued at about $36,000. Clearstead Trust LLC grew its position in shares of Astera Labs by 46,100.0% in the 2nd quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock worth $42,000 after acquiring an additional 461 shares in the last quarter. Ameritas Advisory Services LLC acquired a new stake in shares of Astera Labs during the 2nd quarter valued at approximately $64,000. Finally, Harbour Investments Inc. lifted its position in shares of Astera Labs by 351.7% in the 1st quarter. Harbour Investments Inc. now owns 795 shares of the company’s stock worth $47,000 after buying an additional 619 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. Northland Securities set a $175.00 target price on shares of Astera Labs in a report on Monday. Needham & Company LLC boosted their price objective on Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. Morgan Stanley increased their target price on Astera Labs from $200.00 to $210.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. Deutsche Bank Aktiengesellschaft raised their target price on Astera Labs from $160.00 to $200.00 and gave the company a “buy” rating in a research note on Tuesday, September 2nd. Finally, JPMorgan Chase & Co. upped their price target on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and an average price target of $184.82.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 90,459 shares of Astera Labs stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the transaction, the chief executive officer owned 2,080,418 shares in the company, valued at approximately $301,015,680.42. The trade was a 4.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Manuel Alba sold 183,000 shares of the stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total value of $31,708,410.00. Following the sale, the director owned 385,863 shares of the company’s stock, valued at $66,858,482.01. This trade represents a 32.17% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 619,436 shares of company stock valued at $96,530,060. Corporate insiders own 12.50% of the company’s stock.

Astera Labs Trading Up 1.8%

ALAB stock opened at $142.01 on Thursday. The firm’s 50-day moving average is $188.74 and its two-hundred day moving average is $145.31. The company has a market capitalization of $23.99 billion, a price-to-earnings ratio of 127.94, a price-to-earnings-growth ratio of 2.60 and a beta of 1.37. Astera Labs, Inc. has a 52 week low of $47.13 and a 52 week high of $262.90.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. The firm had revenue of $230.58 million during the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The firm’s quarterly revenue was up 103.9% on a year-over-year basis. During the same period last year, the company posted $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.